Back to today’s briefing

Story perspectives

Roche and Zealand Partner to Transform Obesity Treatment

3/15/2025

25 5

Summary

Story summary

Roche's partnership with Zealand Pharma on petrelintide marks a pivotal moment in the healthcare landscape, as GLP-1 drugs gain prominence in the fight against obesity and diabetes. The promise of oral GLP-1s could revolutionize treatment accessibility, potentially lowering healthcare costs and reshaping insurance coverage for millions.

1 of 1

Story summary

Roche's partnership with Zealand Pharma on petrelintide marks a pivotal moment in the healthcare landscape, as GLP-1 drugs gain prominence in the fight against obesity and diabetes. The promise of oral GLP-1s could revolutionize treatment accessibility, potentially lowering healthcare costs and reshaping insurance coverage for millions.